F. Greten
Oncology · 2001–2021
A researcher in the Science corpus: 16 papers; trusts 22 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 225 citations into it; #159 of 1,698 by trust here, #107 by citations
- Immunology — 154 citations into it; #260 of 2,160 by trust here, #133 by citations
- Molecular Biology — 149 citations into it
- Cancer Research — 88 citations into it; #354 of 1,780 by trust here, #138 by citations
- Genetics — 37 citations into it
- Epidemiology — 35 citations into it
- Psychiatry and Mental health — 10 citations into it; #1,028 of 1,338 by trust here, #102 by citations
- Hepatology — 5 citations into it
Whom F. Greten trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- M. Karin
- S. Grivennikov
- D. Gabrilovich
- D. Hanahan
- F. Balkwill
- Robert Schreiber
- R. Medzhitov
- A. Mantovani
- J. Pollard
- G. Dunn
Who trusts F. Greten overall
- M. Karin
- Bharat B. Aggarwal
- S. Grivennikov
- N. Perkins
- M. Park
- Danyang Li
- P. Moynagh
- Y. Ben‐Neriah
- K. Harikumar
- M. Gyrd-Hansen
Papers from F. Greten's perspective
Ordered by how strongly the researchers F. Greten trusts endorse each paper. Same corpus, a different order for every researcher.
- Hallmarks of cancer: the next generation. (Cell)
- Cancer-related inflammation (Nature)
- Smoldering and polarized inflammation in the initiation and promotion of malignant disease. (Cancer Cell)
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
- De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. (Cancer Cell)
- Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells (Journal of Experimental Medicine)
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- The Hallmarks of Cancer Review
- The STATs of cancer — new molecular targets come of age (Nature Reviews. Cancer)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
Their papers
- A framework for advancing our understanding of cancer-associated fibroblasts (2020) — 3,153 citations
- Inflammation and Cancer: Triggers, Mechanisms and Consequences (2019) — 3,133 citations
- The inflammatory pathogenesis of colorectal cancer (2021) — 654 citations
- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. (2014) — 714 citations
- Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. (2013) — 1,063 citations
- Immunity, Inflammation, and Cancer (2010) — 10,296 citations
- gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (2009) — 993 citations
- NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. (2007) — 646 citations
- IKK-β links inflammation to obesity-induced insulin resistance (2005) — 1,139 citations
- NF-kappaB: linking inflammation and immunity to cancer development and progression. (2005) — 1,397 citations
- IKK-beta links inflammation to obesity-induced insulin resistance. (2005) — 902 citations
- NF-κB: linking inflammation and immunity to cancer development and progression (2005) — 2,086 citations
- NF-kappaB in cancer: from innocent bystander to major culprit. (2002) — 1,162 citations
- NF-κB in cancer: from innocent bystander to major culprit (2002) — 2,450 citations
- Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. (2001) — 646 citations
- Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway (2001) — 1,312 citations